Genetic

Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs

A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVox

Prestigious prize for Belgian breakthrough in brain research

Prof. Dr. Pierre Vanderhaeghen from VIB-KU Leuven has been awarded the Generet Prize for Rare Diseases for his research on […] January 27, 2021 · BioVox

eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Turnstone Communications

A life-changing discovery: CRISPR scientists awarded the 2020 Nobel Prize in Chemistry

After several years of nominations, Emmanuelle Charpentier and Jennifer Doudna have finally been awarded the 2020 Nobel Prize in Chemistry […] November 4, 2020 · BioVox

Can Darwin’s theory explain why we get sick?

While physicians care for their individual patients and are interested in the factors contributing to the individual’s condition, evolutionary biologists […] September 30, 2020 · V-Bio Ventures

Fundamental research leads to treatment breakthrough in rare genetic diseases

A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox

Inari: shaking things up in the agriculture business

Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech [...] February 12, 2020 · Turnstone Communications

New immune system gene discovered in a Flemish boy

Researchers studying a rare disease have identified a new gene responsible for human immune system regulation. An international collaboration combined […] November 26, 2019 · BioVox

A new type of power plants to combat climate change

The prestigious organization EMBO recently announced several new members, including the appointment of VIB-UGent scientist Prof Wout Boerjan. Boerjan joins […] June 27, 2019 · BioVox

Deadly mosquitoes are invading Europe

Due to climate change, two species of tropical mosquitoes are spreading into Europe at increasing rates. Their presence is linked to a range of tropical viruses [...] April 3, 2019 · BioVox

Inari’s agricultural revolution hits Europe with a new site in Ghent

Inari, a U.S. company revolutionizing agricultural R&D, have just opened up their first overseas office in Ghent, Belgium. Partnering with […] February 6, 2019 · Turnstone Communications

What’s next for CRISPR crops in the EU?

Genetically Modification Organisms (GMOs) is one of the most hotly debated topics in the news today. Resistance to GMOs has […] October 9, 2018 · BioVox

Can weeds be programmed to exterminate themselves?

Walking through a forest on a breezy September day, the very air seems to crackle with colour and life. The […] September 11, 2018 · BioVox

How CRISPR/Cas9 is improving drug development using zebrafish

CRISPR/Cas9 came to the attention of scientists everywhere over five years ago. Ever since it hit the main stage, the […] September 4, 2018 · Turnstone Communications

DNA as a storage device for big data

Sometimes science fiction seems to become real right in front of our eyes. Slowly but surely, our genes are revealing […] June 19, 2018 · BioVox

Two genes work together to trigger childhood leukemia

Two known cancer-causing genes, HOXA9 and JAK3/STAT5, are cooperating to trigger acute lymphoblastic leukemia, a common form of childhood cancer. […] April 17, 2018 · BioVox

European collaboration project set to track all human cells

Over sixty leading European scientists are uniting in an ambitious project to track every cell in the human body. The […] April 17, 2018 · BioVox

Big data, big produce – Trends in agri-biotech

In the last few decades, with the introduction of GMOs, the agricultural industry was turned upside down. Major consolidations between […] April 16, 2018 · BioVox

Politicians should consider the consequences of not deploying GM technology

Genetic modification (GM) technology can offer solutions so that farmers can more efficiently grow crops with less environmental impact. Despite […] February 19, 2018 · BioVox

The Cystic Fibrosis association pushes research to the next level

Cystic fibrosis (CF) is a life-threatening disease, for which there is currently no treatment. There are some drugs on the […] February 19, 2018 · BioVox

New cures for hereditary diseases around the corner?

Hereditary diseases are caused by mutations or deletions in (single) genes that lead to either dysfunctional or inadequate levels of […] December 18, 2017 · V-Bio Ventures

Very promising cancer treatment: RNAi immunotherapy

RXi Pharmaceuticals was co-founded by Craig Mello, PhD, the co-recipient of the 2006 Nobel Prize in Medicine for the discovery […] October 10, 2017 · BioVox

Personalized healthcare, a long-awaited revolution

Although it’s already 2017 and medicine has made great progress in the last decade, healthcare is often still very generic, […] September 11, 2017 · Turnstone Communications

Diagnosing rare genetic conditions within minutes

Moon is a new software package that, within minutes, diagnoses patients who suffer from rare diseases. All the software requires […] June 8, 2017 · Turnstone Communications

Designer yeast: synthetic genome closer to reality

Five entirely synthetic yeast chromosomes were created this year. By 2018 every chromosome is expected to have a synthetic couterpart, resulting in en entirely synthetic genome.

May 22, 2017 · BioVox

Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company will build an atlas of DNA found in the blood, convinced major investors, such as Bill Gates and Jeff Bezos, of the technology’s potential. A whopping $1 billion was gathered in the company’s series B financing round. Yet, do Grail and its technology deserve this huge ticket?

March 15, 2017 · V-Bio Ventures